Michelle Tarver, of the FDA's Center for Devices and Radiological Health, said: "Today's clearance is an important step for ...

The USFDA has approved the first-ever blood test to help diagnose Alzheimer's disease, offering a faster, less invasive, and ...

Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.

Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...

Global health stories including rare illnesses, climate change, hypertension, and more, with a focus on little KJ Muldoon's ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...

The first blood test to help diagnose Alzheimer's disease will be available from late June in the US following regulatory ...